No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Eurazeo SE is an investment firm blending private equity and venture capital strategies. It specializes in providing growth capital, executing acquisitions, and facilitating management buyouts (LBOs and buy-ins) of private companies, as well as investing in mid-market enterprises and publicly traded firms. Their equity investments target both small-to-mid and mid-to-large buyout opportunities. The firm targets a diverse range of entities, including medium-to-large businesses, small and medium-sized enterprises (SMEs), high-growth ventures, and opportunities within real estate management and investment. While not restricted to specific sectors, Eurazeo expresses a clear preference for industries such as smart cities, services, leisure, mobility, real estate, fintech, distribution, general industry, luxury goods, consumer products, business services, consumer and retail brands, and healthcare. Within consumer brands, specific areas of interest include beauty, personal care, household items, juvenile products, apparel, wellness, accessories, home decor, jewelry, leisure, health, fitness, beverages, and food companies, primarily those located in the United States and Europe. Eurazeo seeks businesses with distinctive concepts and significant potential for international expansion. The firm proactively identifies and selects companies, often focusing on sectors undergoing digital transformation and adapting to evolving consumer lifestyles and purchasing habits (e.g., mobility, online commerce, collaborative models). Its real estate activities encompass large properties requiring revitalization, various development projects (residential, commercial, and office), and companies possessing real estate assets, predominantly in Western Europe. Geographically, Eurazeo primarily invests across the US, France, Italy, North America, and other European nations. Typically, the firm commits capital ranging from $10 million to €800 million (approximately $892.55 million). It targets companies with enterprise values generally exceeding €150-200 million (around $163.74-$218.30 million) and potentially up to €5000 million (approximately $7108.9 million). Individual investments are capped at 10-15% of its net asset value. Equity or quasi-equity stakes can range from €175 million (approximately $195.25 million) to €800 million (approximately $892.55 million). For transactions exceeding $100 million, Eurazeo often prefers to participate as a co-investor. While frequently seeking majority control in its portfolio companies, it also considers minority investments. Investments in publicly traded companies can involve taking them private through a leveraged buyout, or participating via Private Investment in Public Equity (PIPE) deals. The typical investment horizon is five to seven years. Exit strategies include sales to strategic buyers (manufacturers), financial investors, or public offerings (IPOs). Established in 1969, Eurazeo SE is headquartered in Paris, France, and maintains a global footprint with offices across North America, Asia, Europe, and South America.

• HICL Infrastructure PLC
• Golub Capital BDC, Inc.
• FS KKR Capital Corp.
• Tikehau Capital
• BB Biotech AG
• International Public Partnerships Limited
• WisdomTree, Inc.
• Quilter plc